-
Je něco špatně v tomto záznamu ?
Plasma prohepcidin as a negative acute phase reactant after large cardiac surgery with a deep hypothermic circulatory arrest
P. Maruna, J. Lindner, J. Kunštýř, K. Kubzová, J. Hubáček
Jazyk angličtina Země Česko
Grantová podpora
NR9223
MZ0
CEP - Centrální evidence projektů
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- arteria pulmonalis chirurgie MeSH
- biologické markery krev MeSH
- časové faktory MeSH
- chirurgie operační škodlivé účinky MeSH
- dospělí MeSH
- down regulace MeSH
- endarterektomie škodlivé účinky MeSH
- financování organizované MeSH
- interleukin-6 krev MeSH
- kardiopulmonální bypass škodlivé účinky MeSH
- kationické antimikrobiální peptidy krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- mediátory zánětu krev MeSH
- plicní hypertenze etiologie chirurgie krev MeSH
- proteinové prekurzory krev MeSH
- proteiny akutní fáze MeSH
- sternum chirurgie MeSH
- syndrom systémové zánětlivé reakce etiologie krev MeSH
- tromboembolie chirurgie komplikace krev MeSH
- výsledek terapie MeSH
- zástava krevního oběhu vyvolaná hlubokou hypotermií škodlivé účinky MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
Hepcidin is a key regulator of iron metabolism and a mediator of anemia in inflammation. Recent in vitro studies recognized prohepcidin as a type II acute phase protein regulating via interleukin-6. The aim of the present study was to investigate the time course of plasma prohepcidin after a large cardiac surgery in relation to IL-6 and other inflammatory parameters. Patients with chronic thromboembolic hypertension (n=22, males/females 14/8, age 51.9±10.2 years) underwent pulmonary endarterectomy using cardiopulmonary bypass and deep hypothermic circulatory arrest were included into study. Arterial concentrations of prohepcidin, IL-1ß, IL-6, IL-8, tumor necrosis factor-?, and C-reactive protein were measured before/after sternotomy, after circulatory arrest, after separation from bypass, and then 12, 18, 24, 36, 48 h and 72 h after the separation from bypass. Hemodynamic parameters, hematocrit and markers of iron metabolism were followed up. Pulmonary endarterectomy induced a 48 % fall in plasma prohepcidin; minimal concentrations were detected after separation from cardiopulmonary bypass. Prohepcidin decline correlated with an extracorporeal circulation time (p<0.01), while elevated IL-6 levels were inversely associated with duration of prohepcidin decline. Postoperative prohepcidin did not correlate with markers of iron metabolism or hemoglobin concentrations within a 72-h period after separation from CPB. Prohepcidin showed itself as a negative acute phase reactant during systemic inflammatory response syndrome associated with a cardiac surgery. Results indicate that the evolution of prohepcidin in postoperative period implies the antagonism of stimulatory effect of IL-6 and contraregulatory factors inhibiting prohepcidin synthesis or increasing prohepcidin clearance.
Institute of Clinical and Experimental Medicine Prague Czech Republic
Institute of Pathological Physiology and the 3rd Department of Internal Medicine Prague
Citace poskytuje Crossref.org
Lit.: 21
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10012552
- 003
- CZ-PrNML
- 005
- 20140714105500.0
- 008
- 100525s2009 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931678 $2 doi
- 035 __
- $a (PubMed)19093740
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Maruna, Pavel, $d 1965- $7 xx0000273 $u Institute of Pathological Physiology and the Third Department of Internal Medicine, Prague, Czech Republic
- 245 10
- $a Plasma prohepcidin as a negative acute phase reactant after large cardiac surgery with a deep hypothermic circulatory arrest / $c P. Maruna, J. Lindner, J. Kunštýř, K. Kubzová, J. Hubáček
- 314 __
- $a Institute of Pathological Physiology and the Third Department of Internal Medicine, Prague
- 504 __
- $a Lit.: 21
- 520 9_
- $a Hepcidin is a key regulator of iron metabolism and a mediator of anemia in inflammation. Recent in vitro studies recognized prohepcidin as a type II acute phase protein regulating via interleukin-6. The aim of the present study was to investigate the time course of plasma prohepcidin after a large cardiac surgery in relation to IL-6 and other inflammatory parameters. Patients with chronic thromboembolic hypertension (n=22, males/females 14/8, age 51.9±10.2 years) underwent pulmonary endarterectomy using cardiopulmonary bypass and deep hypothermic circulatory arrest were included into study. Arterial concentrations of prohepcidin, IL-1ß, IL-6, IL-8, tumor necrosis factor-?, and C-reactive protein were measured before/after sternotomy, after circulatory arrest, after separation from bypass, and then 12, 18, 24, 36, 48 h and 72 h after the separation from bypass. Hemodynamic parameters, hematocrit and markers of iron metabolism were followed up. Pulmonary endarterectomy induced a 48 % fall in plasma prohepcidin; minimal concentrations were detected after separation from cardiopulmonary bypass. Prohepcidin decline correlated with an extracorporeal circulation time (p<0.01), while elevated IL-6 levels were inversely associated with duration of prohepcidin decline. Postoperative prohepcidin did not correlate with markers of iron metabolism or hemoglobin concentrations within a 72-h period after separation from CPB. Prohepcidin showed itself as a negative acute phase reactant during systemic inflammatory response syndrome associated with a cardiac surgery. Results indicate that the evolution of prohepcidin in postoperative period implies the antagonism of stimulatory effect of IL-6 and contraregulatory factors inhibiting prohepcidin synthesis or increasing prohepcidin clearance.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a proteiny akutní fáze $7 D000209
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kationické antimikrobiální peptidy $x krev $7 D023181
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a kardiopulmonální bypass $x škodlivé účinky $7 D002315
- 650 _2
- $a zástava krevního oběhu vyvolaná hlubokou hypotermií $x škodlivé účinky $7 D050792
- 650 _2
- $a down regulace $7 D015536
- 650 _2
- $a endarterektomie $x škodlivé účinky $7 D004691
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plicní hypertenze $x etiologie $x chirurgie $x krev $7 D006976
- 650 _2
- $a mediátory zánětu $x krev $7 D018836
- 650 _2
- $a interleukin-6 $x krev $7 D015850
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a proteinové prekurzory $x krev $7 D011498
- 650 _2
- $a arteria pulmonalis $x chirurgie $7 D011651
- 650 _2
- $a syndrom systémové zánětlivé reakce $x etiologie $x krev $7 D018746
- 650 _2
- $a tromboembolie $x chirurgie $x komplikace $x krev $7 D013923
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a sternum $x chirurgie $7 D013249
- 650 _2
- $a chirurgie operační $x škodlivé účinky $7 D013514
- 700 1_
- $a Lindner, Jaroslav, $d 1957- $7 mzk2005269705 $u Second Department of Cardiovascular Surgery, General Teaching Hospital and the First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Kunštýř, Jan. $7 _AN033087 $u Department of Anesthesiology, Resuscitation and Intensive Medicine, General Teaching Hospital and the First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Plocová, Kateřina M. $7 xx0171717 $u Second Department of Cardiovascular Surgery, General Teaching Hospital and the First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 58, č. 6 (2009), s. 827-833 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/58/58_827.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8 $z 0
- 990 __
- $a 20100525095435 $b ABA008
- 991 __
- $a 20140714105758 $b ABA008
- 999 __
- $a ok $b bmc $g 726409 $s 589563
- BAS __
- $a 3
- BMC __
- $a 2009 $b 58 $c 6 $d 827-833 $m Physiological research $x MED00003824
- GRA __
- $a NR9223 $p MZ0
- LZP __
- $a 2010-28/ipme